Sinonasal polyposis (SP) is an inflammatory disease involving multiple etiologies and pathogenesis. The disarray of Interleukin (IL)-10 is associated with a raised immunopathological response during the progression of many autoimmune diseases as well as the response to infection. We studied the possible role of the single nucleotide polymorphisms 
INTRODUCTION
Sinonasal polyposis (SP) is a cronic inflammation of the sinonasal mucosa. Chronic sinusitis, odor loss headache and nasal obstruction are among the clinical symptoms of SP with low life quality among the patients. Sinonasal polyposis is often accompanied by allergic rhinitis, allergy, aspirin susceptibility and asthma [1] . SP has been implicated in many immunological pathways and is a localized manifestation of systemic disorders [2, 3] . SP cases frequently accompanied by T helper (Th) type 1-, Th2-, or Th17-biased inflammatory processes regulated by increased expression levels of a number of cytokines with pro-and anti-inflammatory activities [4] . However, the underlying etiology of SP is multifactorial. Also the pathogenesis of SP is still unexplained.
İnterleukin (IL)-10 is a crucial Th2 group anti-inflammatory cytokine. IL-10 plays an important role in defense against host pathogens, protection against excessive tissue damage, and development of immune response [5, 6] . Since the increased IL-10 gene expression triggers local inflammatory response that result in increased tissue damage, it has been associated with many chronic inflammatory diseases. Various studies have demonstrated that the levels of IL-10 in serum [7] , blood [8] , nasal secretion [9] and tissue samples significantly increased [10] .
In addition, Xu et al [11] had shown an increase in IL-10 mRNA level and had claimed that it could have played a role in SP pathogenesis. various disease pathogenesis [12, 13] .
We studied the IL-10 -1082, -819, and -592 SNPs and their genotypic combinations in SP patients and controls to investigate the role of IL-10 in pathogenesis of SP in this study.
METHODS

Subjects
The samples used in this study were obtained from the individuals who were admitted to otorhinolaryngology clinic. One hundred (mean age 45.5945 ± 10.031; range: 22-64 years)
patients with SP were included. Patients were received to the clinic with complaints of nasal obstruction/congestion, loss or reduction of smell, facial pressure and poor quality of life. The patients were diagnosed with nasal endoscopic examination as SP [3] . In the last four weeks,
The patients that had an acute upper respiratory tract infection, cystic fibrosis, inverted papillomas, fungal sinusitis, and antrochoanal polyps were not included in the study.
According to the Lund-Mackay system, computed tomography scanning of paranasal sinus were acquired and evaluated [14] . The size of the polyp was classified according to the Lidtholdt scale [15] . The presence of asthma and aspirin susceptibility were assessed in the clinical history and the allergy presence was assessed by prick skin test.
A 100 (mean age 44.62 ± 11.615; range 18-63 years) healthy volunteer subjects with no history of sinonasal disorder, inflammatory-related disorder or any other disease was included in the control group. In addition, absence of rhinosinusitis and SP were confirmed with the nasal endoscopic examination. The study has ethics committee approval.
A c c e p t e d M a n u s c r i p t N o t C o p y e d i t e d
Genotyping
The genomic DNA was extracted from blood sample with kit (Qiagen Inc.). The polymerase chain reaction (PCR) for direct sequencing was used to amplify specific regions of the IL-10 gene's promotor and primer's designs were summarized in Table 1 . 
Statistical analysis
SPSS version 16.0 was used for statistical analysis. The genotypic distributions were checked consistency with Hardy-Weinberg-Equilibrium (HWE) [16] . The genotypic and haplotypic frequencies were evaluated using a software (http://bioinfo.iconcologia.net/SNPstats) [17] . Pvalue < 0.05 was considered significant. The Multifactor Dimensionality Reduction (MDR)
package software was performed all potential recognition of SNP-SNP interactions and that are fine identified as playing a significant role in insight complicated properties. MDR has the testing balance accuracy (TBA) and cross-validation consistency (CVC) [18] .
RESULTS
SP and control groups were similar in age distribution and gender (P> 0.05). The demographic data of the subjects shown in Table 2 .
The genotypic distributions in the controls found consistent with the HWE (for -1082 P= 0.47;
for -819 P= 0.07; for -592 P= 1). In patients with SP, DNA sequence analysis of the IL-10 gene revealed that in all genetic models carrying the A allele for -1082 (G>A), the dominant and logaddictive genetic model carrying the T allele for -819 (C>T), the genotype frequencies in all other genetic models except the overdominant model bearing the A allele for -592 (C>A) were A c c e p t e d M a n u s c r i p t N o t C o p y e d i t e d statistically significant (P < 0.05 for all). We also found that the minor allele frequencies for three SNPs were significantly elevated in patients with SP, and summarized in Table 3 .
The IL-10 ACC, GTC, GCA haplotype frequencies were higher in patients with SP. Morever the ATA haplotype was only in patients, but the GTA only in the controls (-1082, -819, -592, respectively) (P< 0.05) ( Table 4) .
MDR analysis was evaluated all potantial combinations, and two models for SP's prediction were found. Binary SNP interplay between the best two-locus predictive model IL-10-1082_- Malagutti and colleagues found that the IL-10 serum levels in sinonasal polyposis patients were significantly higher, and examined the exonic and intronic regions of the IL-10 by DNA sequencing. In that study, it was reported that some intronic genotypes of the IL-10 were found to be highly frequent in the patients (30%) and that these genotypes might cause high serum levels of IL-10. In advanced studies, it has been reported that the genetic polymorphisms of promoter and regulatory region in the IL-10 may be critical in the polyp genesis of sinonasal polyposis patients [19, 20] . However, far as we know, there is no study investigating the gene in control groups vary, and they are same to last studies in Turkish society [13, 21, 22] .
In addition, the current study, the effect of IL-10 gene promoter SNPs on clinical heterogeneity of the disease was investigated by separating the patient group into subgroups according to clinical characteristics such as CT score, asthma presence, aspirin susceptibility, allergy presence and polyp phase, and no connection was observed.
The frequencies of IL10-1082GA, AA, GA-AA and AA genotypes containing the minor allele were found to be higher and statistically significant compared to IL-10-1082GG, GG-GA and GG-AA genotypes in SP patients. Furthermore, the frequency of IL10-819CT, TT genotypes containing the minor allele was found to be higher and statistically significant compared to IL- The estimated frequency of haplotypes formed by the investigated SNPs was calculated in the control and patient groups. The haplotypes GCC, ACC and GCA were commonly observed whereas ATA and GTA haplotypes were less frequent (< 0.01). The distribution of haplotypes was significantly different between patients and controls. Based on the most common haplotype (GCC) in the control group, the probability rate of other haplotypes was assessed. When compared, a significant difference was observed between the patient and the control group for ACC, GTC and GCA haplotypes. This data show that those carrying the ACC, GTC and GCA haplotypes are at a greater risk of developing SP than those carrying the GCC haplotype. The disease is not associated with a single mutation or allelic variation, but may occur with the common effect of multiple SNPs or mutations. When rare alleles come together, they can prepare the ground for disease. These rare alleles with the contribution of environmental factors may also be critical in the pathogenesis of the disorder [23] . However, considering these haplotypes and their frequencies, further research is needed to reach a definite conclusion.
According to the tree-locus model MDR analysis, GG+CT+CC, GG+CT+CA, GA+CC+CC
and GA+CT+CA triplotype had 6-, 4-, 2.3-and 1.5-fold risk of developing SP.
The haplotypes of the IL-10 gene SNPs also show ethnic differences. These polymorphisms may constitute a variety of haplotypes, but generally only three haplotypes (ATA, ACC, GCC)
with GCC (50-52%) as the most common have been identified [24, 25] . In the previous studies, haplotypes were shown to be the combinations carrying GCC, ACC, or ATA alleles at IL-10-1082, -592 junctions [7, 8, 12] . The haplotypes and their frequencies found in our study are consistent with the literature. alleles and that the -1082 allele has a predictive value in determining IL-10 secretion levels [7, 8, 12] .
In studies related to SP pathogenesis it was reported that there was an unbalance between Th1 and 2 cytokines including IL-10 (Th1/Th2) ratio, and IL-10's levels in serum were especially high in eosinophilic sinonasal polyposis and allergic or asthmatic sinonasal polyposis [7, 19] . In our study, although the level of IL-10 serum was not investigated, 34% of patients with SP were asthmatic, 19% were aspirin sensitive and 35% were allergic. 
CONCLUSIONS
In conclusion, the IL-10's genotypic variations in SP patients were examined. The genotypes and haplotypes including the -1082A, -819T and -592A minor alleles that were associated with SP susceptibility, affecting the level of genetic expression, altering the severity of inflammation and contributing to SP development were identified in our study. 
